Skip to main content
NIH funding notice RFA-DK-22-513

Single Source for the Continuation of Cure Glomerulonephropathy (CureGN) Data Coordinating Center (U24 Clinical Trial Not Allowed)

Closed on October 19, 2023.

Posted
July 13, 2023
Close date
October 19, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 renewal
First-year cost
$1,399,999
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. UNIVERSITY OF MICHIGAN AT ANN ARBOR1

Most frequent study sections

  1. Special Emphasis Panel (ZDK1 GRB-6 (M1))1
1 award under RFA-DK-22-513 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2024CureGN2U24DK100845-12Gadegbeku, Crystal A.Mariani, Laura HSmith, AbigailUNIVERSITY OF MICHIGAN AT ANN ARBOR, MIFirst-year cost $1,399,999Study section ZDK1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-DK-22-513: Single Source for the Continuation of Cure Glomerulonephropathy (CureGN) Data Coordinating Center (U24 Clinical Trial Not Allowed) | ScienceDex | ConductScience